Lv22
178 积分 2023-10-09 加入
Effects of the DPP-1 inhibitor HSK31858 in adults with bronchiectasis in China (SAVE-BE): a phase 2, multicentre, double-blind, randomised, placebo-controlled trial
1天前
已完结
US FDA 505(b)(2) NDA clinical, CMC and regulatory strategy concepts to expedite drug development
1个月前
已完结
Review on 505(b)(2) Drug Products Approved by USFDA from 2010 to 2020 Emphasizing Intellectual Property and Regulatory Considerations for Reformulations and New Combinations
1个月前
已完结
Pre-clinical safety and efficacy of human induced pluripotent stem cell-derived products for autologous cell therapy in Parkinson’s disease
2个月前
已完结
Pre-clinical safety and efficacy of human induced pluripotent stem cell-derived products for autologous cell therapy in Parkinson’s disease
2个月前
已完结
COMPARING THE QUALITY ASSAYS OF IPSC-DERIVED RPE GENERATED FROM AUTOLOGOUS VS ALLOGENEIC APPROACHES
2个月前
已完结
COMPARING THE QUALITY ASSAYS OF IPSC-DERIVED RPE GENERATED FROM AUTOLOGOUS VS ALLOGENEIC APPROACHES
2个月前
已完结
FROM AUTOLOGOUS CELL BANKING TO ALLOGENEIC CELL THERAPY MANUFACTURING: DEVELOPING A CMC STRATEGY FOR THE PRODUCTION OF A GMP-COMPLIANT MSC-BASED THERAPY
2个月前
已完结
Preliminary efficacy and safety of YSCH-01 in patients with advanced solid tumors: an investigator-initiated trial
2个月前
已完结
皖公网安备34019202002308
